FY2025 EPS Estimates for Transcat Decreased by Analyst

Transcat, Inc. (NASDAQ:TRNS) – Research analysts at Northland Capmk dropped their FY2025 EPS estimates for shares of Transcat in a research report issued on Wednesday, October 30th. Northland Capmk analyst E. Jackson now expects that the scientific and technical instruments company will earn $1.88 per share for the year, down from their previous forecast of $2.00. The consensus estimate for Transcat’s current full-year earnings is $2.06 per share. Northland Capmk also issued estimates for Transcat’s FY2027 earnings at $2.69 EPS and FY2028 earnings at $2.99 EPS.

TRNS has been the subject of several other research reports. Craig Hallum reduced their price objective on shares of Transcat from $138.00 to $113.00 and set a “buy” rating for the company in a research note on Wednesday. Oppenheimer reiterated an “outperform” rating and issued a $130.00 price target (down from $155.00) on shares of Transcat in a research note on Wednesday. StockNews.com lowered Transcat from a “hold” rating to a “sell” rating in a research note on Tuesday. HC Wainwright reaffirmed a “buy” rating and issued a $156.00 price objective on shares of Transcat in a research report on Tuesday. Finally, Northland Securities dropped their target price on shares of Transcat from $130.00 to $110.00 and set a “market perform” rating on the stock in a research report on Wednesday. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $127.25.

Transcat Price Performance

Shares of NASDAQ TRNS opened at $95.41 on Friday. The stock has a market capitalization of $873.00 million, a P/E ratio of 48.19 and a beta of 0.67. The business has a fifty day moving average price of $121.71 and a 200 day moving average price of $121.89. Transcat has a 1-year low of $84.45 and a 1-year high of $147.12.

Transcat (NASDAQ:TRNS) last issued its quarterly earnings data on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.12). The business had revenue of $67.83 million for the quarter, compared to analysts’ expectations of $70.30 million. Transcat had a net margin of 6.63% and a return on equity of 7.62%. The business’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.41 earnings per share.

Institutional Investors Weigh In On Transcat

A number of institutional investors and hedge funds have recently modified their holdings of TRNS. Principal Financial Group Inc. lifted its position in Transcat by 8.8% during the third quarter. Principal Financial Group Inc. now owns 4,611 shares of the scientific and technical instruments company’s stock valued at $557,000 after purchasing an additional 373 shares during the period. Conestoga Capital Advisors LLC boosted its stake in shares of Transcat by 17.9% in the third quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company’s stock worth $109,561,000 after buying an additional 137,830 shares during the last quarter. US Bancorp DE grew its holdings in Transcat by 15.6% during the third quarter. US Bancorp DE now owns 1,547 shares of the scientific and technical instruments company’s stock worth $187,000 after acquiring an additional 209 shares during the period. Wealth Enhancement Advisory Services LLC raised its position in Transcat by 28.8% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 79,303 shares of the scientific and technical instruments company’s stock valued at $9,577,000 after acquiring an additional 17,743 shares in the last quarter. Finally, Arkadios Wealth Advisors lifted its holdings in Transcat by 38.7% in the third quarter. Arkadios Wealth Advisors now owns 6,118 shares of the scientific and technical instruments company’s stock valued at $739,000 after acquiring an additional 1,707 shares during the period. Institutional investors and hedge funds own 98.34% of the company’s stock.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.